May 15, 2017
Ranked as one of the Top 50 Fastest Growing Private Companies in Massachusetts
February 1, 2017
November 7, 2016
Veristat Strengthens its Clinical Operations, Medical and Regulatory Affairs Offerings
SOUTHBOROUGH, MA – November 07, 2016 – Veristat announced that it has appointed James (Jim) Roach, MD, FACP, FCCP as its new Chief Medical Officer to bolster the expansion of its clinical operations, medical and regulatory affairs offerings.
November 1, 2016
SOUTHBOROUGH, MA – November 01, 2016 – Veristat, a full service consultative Clinical Research Organization (CRO), announced today the formal launch of its Strategic Decision Consulting service offering to help pharmaceutical, biotechnology and medical device firms solve the unique and complex challenges they face throughout the development process.
September 20, 2016
Veristat, a full service Clinical Research Organization (CRO), announced today the signing of a Preferred Provider Agreement (PPA) with Aegerion Pharmaceuticals Inc. (“Aegerion”), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. Veristat has assisted Aegerion with US Food and Drug Administration, EU Market Authorization Application, and Japan Food and Drug Administration submission projects over the past 5 years.
Veristat Acknowledged for its Rapid Growth on the Inc. 5000 List of America’s Fastest-Growing Private Companies
August 17, 2016
Veristat Continues To Be Recognized for Its Positive Impact & Company Growth
SOUTHBOROUGH, MA – August 17, 2016 – Veristat announced today that it has been recognized once again by Inc. Magazine as one of America’s fastest-growing private companies. Veristat debuted on the list in 2015.
Veristat Article “Adaptive Designs- Recent Advancement in Clinical Trials” Published in “Journal of Bioanalysis & Biostatistics”
July 14, 2016
Accelerates Hiring & Plans to Open Office in Raleigh-Durham, North Carolina
Veristat Strengthens Statistical Consulting and Adaptive Design Trial Expertise With Appointment of Mark Chang
June 15, 2016
Appoints Mark Chang as Senior Vice President of Strategic Statistical Consulting
SOUTHBOROUGH, MA – June 15, 2016 – Veristat, a full service Clinical Research Organization (CRO), announced that it has strengthened its statistical consulting and adaptive design expertise with the appointment of Mark Chang, PhD to the newly created position of Senior Vice President of Strategic Statistical Consulting. Dr. Chang will help clients evaluate and implement strategic, operational and technical efficiencies to advance products through the clinical trial and regulatory submission process.